Human Vaccines & Immunotherapeutics · 2014 · 20 citations · 27 references
Veterinary MedicineImmunologyInfectious DiseasesImmunizationVaccine ImmunologyVaccinologyAdverse Events Following ImmunizationClinical Vaccine TrialsVaccinationVaccine ReactogenicityVaccine SafetyVaccine-preventable DiseasesAdverse Vaccine ReactionsAge-specific Vaccine TrialsComparative Vaccine SafetyMumps VaccinationSafety Of Subunit VaccinesSerious Adverse Event DetectionSubunit Vaccine SafetyVaccine Characterization
BACKGROUND: Mumps, a communicable, acute and previously well-controlled disease, has had recent and occasional resurgences in some areas. METHODS: A randomized, double-blind, controlled and multistep phase I study of an F-genotype attenuated mumps vaccine produced in human diploid cells was conducted. A total of 300 subjects were enrolled and divided into 4 age groups: 16-60 years, 5-16 years, 2-5 years and 8-24 months. The groups were immunized with one injection per subject. Three different doses of the F-genotype attenuated mumps vaccine, A (3.5 ± 0.25 logCCID50), B (4.25 ± 0.25 logCCID50) and C (5.0 ± 0.25 logCCID50), as well as a placebo control and a positive control of a licensed A-genotype vaccine (S79 strain) were used. The safety and immunogenicity of this vaccine were compared with those of the controls. RESULTS: The safety evaluation suggested that mild adverse reactions were observed in all groups. No serious adverse event (SAE) was reported throughout the trial. The immunogenicity test showed a similar seroconversion rate of the neutralizing and ELISA antibody in the 2- to 5-year-old and 8- to 24-month-old groups compared with the seroconversion rate in the positive control. The GMT of the neutralizing anti-F-genotype virus antibodies in the vaccine groups was slightly higher than that in the positive control group. CONCLUSIONS: The F-genotype attenuated mumps vaccine evaluated in this clinical trial was demonstrated to be safe and have effective immunogenicity vs. control.
27
Jill Watson, Stephen C. Hadler, Clare A. Dykewicz et al. · PsycEXTRA Dataset · 1998 · 586 citations
Recent Resurgence of Mumps in the United States
Gustavo H. Dayan, M. Patricia Quinlisk, Amy A. Parker et al. · New England Journal of Medicine · 2008 · 402 citations · Full text
Mumps outbreak in a highly vaccinated population
Bradley S. Hersh, Paul Fine, W. Kay Kent et al. · The Journal of Pediatrics · 1991 · 161 citations
Veterinary Medicine, Infectious Disease Control, Infectious Diseases +14
Summary of notifiable diseases--United States, 2004.
PubMed · 2006 · 153 citations
Public Health, Infectious Disease Control, Infectious Diseases +17